Literature DB >> 6404210

Radioimmunoassay of sodium cromoglycate in human plasma.

K Brown, J J Gardner, W J Lockley, J R Preston, D J Wilkinson.   

Abstract

A sensitive radioimmunoassay method for sodium cromoglycate in human plasma is described. The lowest quantifiable concentration of sodium cromoglycate is 0.93 nmol/l when 0.1 ml plasma samples are analysed. Direct analysis of sodium cromoglycate concentrations in plasma samples collected up to several hours after the administration of single therapeutic doses of the compound is possible. An antiserum raised in a sheep, radioligand heterogeneously labelled with iodine-125, and a second antibody technique for the separation of bound and free radioligand are employed. The inter-assay coefficient of variation is less than 14% (n = 23). The range of the method is limited; both 0.01 and 0.1 ml volumes of plasma must be analysed to encompass the concentration range 0.93-139 nmol/l which may be encountered in plasma samples from patients and human volunteers. The method is specific for sodium cromoglycate as indicated by a low cross-reactivity of the anti-cromoglycate antiserum with a number of drugs.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6404210     DOI: 10.1177/000456328302000105

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  11 in total

1.  Delivery of therapeutic aerosols to intubated babies.

Authors:  J Grigg; S Arnon; T Jones; A Clarke; M Silverman
Journal:  Arch Dis Child       Date:  1992-01       Impact factor: 3.791

2.  How much aerosol reaches the lungs of wheezy infants and toddlers?

Authors:  B Salmon; N M Wilson; M Silverman
Journal:  Arch Dis Child       Date:  1990-04       Impact factor: 3.791

3.  Inhaled histamine increases the rate of absorption of sodium cromoglycate from the lung.

Authors:  R Richards; C Fowler; S Simpson; A G Renwick; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1992-03       Impact factor: 4.335

4.  The pharmacokinetics of sodium cromoglycate in man after intravenous and inhalation administration.

Authors:  M G Neale; K Brown; R W Hodder; R M Auty
Journal:  Br J Clin Pharmacol       Date:  1986-10       Impact factor: 4.335

5.  Plasma concentrations of sodium cromoglycate given by nebulisation and metered dose inhalers in patients with exercise-induced asthma: relationship to protective effect.

Authors:  K R Patel; W M Tullett; M G Neale; R T Wall; K M Tan
Journal:  Br J Clin Pharmacol       Date:  1986-02       Impact factor: 4.335

6.  Comparison of lung deposition of a solution after nebulization by three commonly used portable nebulizers.

Authors:  R A Foulds; L O Smithuis
Journal:  Pharm Weekbl Sci       Date:  1983-04-29

7.  Crying significantly reduces absorption of aerosolised drug in infants.

Authors:  R Iles; P Lister; A T Edmunds
Journal:  Arch Dis Child       Date:  1999-08       Impact factor: 3.791

8.  The influence of liposomal encapsulation on sodium cromoglycate pharmacokinetics in man.

Authors:  K M Taylor; G Taylor; I W Kellaway; J Stevens
Journal:  Pharm Res       Date:  1989-07       Impact factor: 4.200

9.  Deep inspiration increases the absorption of inhaled sodium cromoglycate.

Authors:  R Richards; C Fowler; S F Simpson; A G Renwick; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1989-06       Impact factor: 4.335

10.  Sodium cromoglycate in asthma: correlation between response and serum concentrations.

Authors:  Y Yahav; S Dany; D Katznelson; Z Farfel
Journal:  Arch Dis Child       Date:  1988-06       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.